UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE
SECURITIES EXCHANGE ACT OF 1934
For the month of July 2017
Commission File No. 00-30082
MERUS LABS INTERNATIONAL
INC.
(Translation of registrant's name into English)
100 Wellington St. West, Suite 2110 P.O. Box
151
Toronto, ON M5K 1H1
(Address of principal
executive office)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F
Form 20-F
[ ] Form 40-F [X]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) [ ]
SUBMITTED HEREWITH
| Exhibits | |
| 99.1 | News release dated July 10, 2017 re: Merus Labs International Inc. Shareholders Approve Plan of Arrangement with Norgine B.V. |
| 99.2 | Report of Voting Results |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: July 10, 2017 | |
| MERUS LABS INTERNATIONAL INC. | |
| /s/ Dr. Michael Bumby | |
| Dr. Michael Bumby | |
| Chief Financial Officer |